Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial J Martin-Broto, S Stacchiotti, A Lopez-Pousa, A Redondo, D Bernabeu, ... The Lancet Oncology 20 (1), 134-144, 2019 | 107 | 2019 |
Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial J Martin-Broto, N Hindi, G Grignani, J Martinez-Trufero, A Redondo, ... Journal for immunotherapy of cancer 8 (2), 2020 | 98 | 2020 |
A comprehensive review on solitary fibrous tumor: new insights for new horizons J Martin-Broto, JL Mondaza-Hernandez, DS Moura, N Hindi Cancers 13 (12), 2913, 2021 | 75 | 2021 |
VRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced by DNA damage M Salzano, M Sanz-García, DM Monsalve, DS Moura, PA Lazo Epigenetics 10 (5), 373-383, 2015 | 65 | 2015 |
Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial J Martin-Broto, J Cruz, N Penel, A Le Cesne, N Hindi, P Luna, DS Moura, ... The Lancet Oncology 21 (3), 456-466, 2020 | 60 | 2020 |
Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for … J Martin-Broto, A Redondo, C Valverde, MA Vaz, J Mora, XG Del Muro, ... Annals of Oncology 28 (12), 2994-2999, 2017 | 59 | 2017 |
VRK1 and AURKB form a complex that cross inhibit their kinase activity and the phosphorylation of histone H3 in the progression of mitosis DS Moura, I Campillo-Marcos, M Vázquez-Cedeira, PA Lazo Cellular and molecular life sciences 75, 2591-2611, 2018 | 40 | 2018 |
Assessment of safety and efficacy of combined trabectedin and low-dose radiotherapy for patients with metastatic soft-tissue sarcomas: a nonrandomized phase 1/2 clinical trial J Martin-Broto, N Hindi, A Lopez-Pousa, J Peinado-Serrano, R Alvarez, ... JAMA oncology 6 (4), 535-541, 2020 | 37 | 2020 |
Facts and hopes in immunotherapy of soft-tissue sarcomas J Martín-Broto, DS Moura, BA Van Tine Clinical Cancer Research 26 (22), 5801-5808, 2020 | 29 | 2020 |
IMMUNOSARC: A collaborative Spanish (GEIS) and Italian (ISG) sarcoma groups phase I/II trial of sunitinib plus nivolumab in advanced soft tissue and bone sarcomas: Results of … JM Broto, N Hindi, GE Grignani, JM Trufero, A Redondo, C Valverde, ... Annals of Oncology 30, v684, 2019 | 25* | 2019 |
Nilotinib as coadjuvant treatment with doxorubicin in patients with sarcomas: a phase I trial of the spanish group for research on sarcoma R Alemany, DS Moura, A Redondo, J Martinez-Trufero, S Calabuig, ... Clinical Cancer Research 24 (21), 5239-5249, 2018 | 24 | 2018 |
New drugs in gastrointestinal stromal tumors J Martin-Broto, DS Moura Current opinion in oncology 32 (4), 314-320, 2020 | 21 | 2020 |
CYP1A1 m1 and m2 polymorphisms: genetic susceptibility to lung cancer P Mota, DS Moura, MG Vale, H Coimbra, L Carvalho, F Regateiro Revista Portuguesa de Pneumologia (English Edition) 16 (1), 89-98, 2010 | 21 | 2010 |
Oncogenic Sox2 regulates and cooperates with VRK1 in cell cycle progression and differentiation DS Moura, IF Fernández, G Marín-Royo, I López-Sánchez, ... Scientific reports 6 (1), 28532, 2016 | 18 | 2016 |
Trabectedin plus radiotherapy for advanced soft-tissue sarcoma: experience in forty patients treated at a sarcoma reference center N Hindi, I Carrasco García, A Sánchez-Camacho, A Gutierrez, J Peinado, ... Cancers 12 (12), 3740, 2020 | 17 | 2020 |
Herpesviral infection in a Guiana dolphin (Sotalia guianensis) from the northern coast of Brazil GCC Seade, VD Cerqueira, E Sierra, JF Chaves, MAO Moura, DP Montão, ... Journal of veterinary diagnostic investigation 29 (6), 877-879, 2017 | 17 | 2017 |
A DNA damage repair gene‐associated signature predicts responses of patients with advanced soft‐tissue sarcoma to treatment with trabectedin DS Moura, M Peña‐Chilet, JA Cordero Varela, R Alvarez‐Alegret, ... Molecular Oncology 15 (12), 3691-3705, 2021 | 13 | 2021 |
Cancer stem cells in soft-tissue sarcomas P Martínez-Delgado, S Lacerenza, A Obrador-Hevia, M Lopez-Alvarez, ... Cells 9 (6), 1449, 2020 | 13 | 2020 |
SELNET clinical practice guidelines for bone sarcoma JY Blay, E Palmerini, J Bollard, S Aguiar, M Angel, B Araya, R Badilla, ... Critical Reviews in Oncology/Hematology 174, 103685, 2022 | 11 | 2022 |
CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research … DS Moura, P Sanchez-Bustos, A Fernandez-Serra, M Lopez-Alvarez, ... Cancers 12 (5), 1128, 2020 | 10 | 2020 |